Rising role of 3D-printing in delivery of therapeutics for infectious disease

Anthony J. Kyser,Bassam Fotouh,Mohamed Y. Mahmoud,Hermann B. Frieboes
DOI: https://doi.org/10.1016/j.jconrel.2023.12.051
IF: 11.467
2024-01-10
Journal of Controlled Release
Abstract:Modern drug delivery to tackle infectious disease has drawn close to personalizing medicine for specific patient populations. Challenges include antibiotic-resistant infections, healthcare associated infections , and customizing treatments for local patient populations. Recently, 3D-printing has become a facilitator for the development of personalized pharmaceutic drug delivery systems. With a variety of manufacturing techniques, 3D-printing offers advantages in drug delivery development for controlled, fine-tuned release and platforms for different routes of administration. This review summarizes 3D-printing techniques in pharmaceutics and drug delivery focusing on treating infectious diseases, and discusses the influence of 3D-printing design considerations on drug delivery platforms targeting these diseases. Additionally, applications of 3D-printing in infectious diseases are summarized, with the goal to provide insight into how future delivery innovations may benefit from 3D-printing to address the global challenges in infectious disease.
pharmacology & pharmacy,chemistry, multidisciplinary
What problem does this paper attempt to address?